Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe-Reference-Cited by-同舟云学术

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

Published:2023-04 Issue:2 Volume:8 Page:101197
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

de With M.,Sadlon A.,Cecchin E.,Haufroid V.,Thomas F.,Joerger M.,van Schaik R.H.N.,Mathijssen R.H.J.,Largiadèr C.R.

Funder

European Commission

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. European Medicines Agency (EMA). Summary of product characteristics (SmPC) Capecitabine Xeloda. Available at https://www.ema.europa.eu/en/documents/product-information/xeloda-epar-product-information_en.pdf. Accessed March 20, 2023.

2. Medicines Evaluation Board (MEB). Summary of product characteristics (SmPC) fluorouracil 50 mg/ml solution for injection or infusion. Available at https://www.geneesmiddeleninformatiebank.nl/smpc/h100701_smpc.pdf. Accessed March 20, 2023.

3. Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data;Meulendijks;Lancet Oncol,2015

4. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

5. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial;Koopman;Lancet,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid determination of uracil in biological fluids at mercury thin film electrode for early detection of potential 5-fluorouracil toxicity due to dihydropyrimidine dehydrogenase deficiency;Biosensors and Bioelectronics;2024-10

2. Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD);International Journal of Molecular Sciences;2024-07-11

3. Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US;Supportive Care in Cancer;2024-07-09

4. Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review;Journal of Modern Oncology;2024-07-03

5. Can we identify patients carrying targeted deleterious DPYD variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis;Clinical Chemistry and Laboratory Medicine (CCLM);2024-06-19